3.90 (7.77%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Strong
Garp
Very Strong
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Strong
Earnings
Very Strong
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Website
BioMarin Pharmaceutical Inc.
Telephone
1.415.506.6700
Address
770 Lindaro Street, San Rafael, CA 94901
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 49.26 - 66.28
Trade Value (12mth)
US$32,645,604.00
1 week
-3.11%
1 month
-7.29%
YTD
-15.56%
1 year
-13.46%
All time high
151.75
EPS 3 yr Growth
138.10%
EBITDA Margin
30.00%
Operating Cashflow
$828m
Free Cash Flow Return
12.70%
ROIC
5.40%
Interest Coverage
89.20
Quick Ratio
3.50
Shares Outstanding (Fully Diluted)
198m
HALO Sector
Healthcare
Next Company Report Date
24-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 06 May 26 | |
| 06 May 26 | |
| 05 May 26 | |
| 05 May 26 | |
| 27 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 0.89 | 2.25 | 1.82 | | | | ||
EPS (Fully Diluted) | $ | | | | | 0.88 | 2.21 | 1.8 | | | | ||
Growth | % | | | | | 16.8 | 151.7 | -19 | | | | ||
PE | X | | | | | 110.2 | 29.8 | 32.9 | | | | ||
EV/EBITDA | X | | | | | 61.9 | 19.8 | 11.1 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
